ITMCTR2100004561招募中1 期
Study on clinical efficacy and mechanism of combined acupuncture and medicine for treatment of knee osteoarthritis
Dongzhimen Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 45 至 75(—)
- 性别
- All
入选标准
- •1. Patients who meet the diagnostic criteria of Western medicine by KOA and meet the syndromes of TCM with yang deficiency or yin deficiency (refer to the Classification and Judgment Criteria for Constitution of Traditional Chinese Medicine issued by the Chinese Society of Traditional Chinese Medicine in 2009 to determine the constitution of KOA patients);
- •2. 45 years old <= age <= 75 years old, no gender limit;
- •3. The radiological examination within 6 months shows that the KL classification is I-III;
- •4. Have not received analgesia or acupuncture within 2 weeks before participating in the trial;
- •5. Visual analogue scale (VAS)>= 4;
- •6. Sign the informed consent and volunteer to participate in this research.
排除标准
- •1. Knee pain caused by other diseases, such as knee tuberculosis, tumors, rheumatism and rheumatoid arthritis;
- •2. Patients with a history of knee surgery;
- •3. Patients with severe primary diseases of cardiovascular, cerebrovascular, blood, and digestive systems, severely impaired liver and kidney function, and mental illness;
- •4. Women who are pregnant or breastfeeding, and those who are preparing to become pregnant;
- •5. It is known to have peptic ulcer or active bleeding, so it is not suitable to take backup medicine;
- •6. Participating in other clinical studies within the past month will not be allowed to participate in this study.
研究者
相似试验
招募中
不适用
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000009107Iwate Medical University60
尚未招募
2 期
The therapeutic effect of the combination of altplas and ibtifibatide (integrilin) in comparison with altplas (r-TPA) alone, in the treatment of acute ischemic strokeAcute Ischemic Stroke.Cerebellar stroke syndromeG46.4IRCT20170117032025N9Hamedan University of Medical Sciences50
已完成
Unknown
• Comparison of graft loss rate in patients receiving ivig drug with patients receiving ivig and leflunomide regimen.patients with BK virus infection in kidney transplant patients.Kidney transplant infectioT86.13IRCT20230214057417N1Shiraz University of Medical Sciences30
招募中
2 期
The effect of erbium laser in striaestriae distensae.Striae atrophicaeL90.6IRCT20220322054341N2Skin and Stem Cell Research Center of Tehran University of Medical Sciences10
已完成
不适用
Study on effect and safety for combination of immune checkpoint inhibitor and molecular-targeted therapies for liver cancerunresectable hepatocellular carcinomaJPRN-UMIN000043639agoya University Hospital91
